We are live on ! Find out more

690 hedge funds and large institutions have $13.4B invested in Xylem in 2019 Q2 according to their latest regulatory filings, with 75 funds opening new positions, 239 increasing their positions, 248 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 46

49% more call options, than puts

Call options by funds: $21.2M | Put options by funds: $14.2M

7% more capital invested

Capital invested by funds: $12.5B → $13.4B (+$900M)

3% more funds holding

Funds holding: 668690 (+22)

4% less repeat investments, than reductions

Existing positions increased: 239 | Existing positions reduced: 248

1.1% less ownership

Funds ownership: 88.04%86.95% (-1.1%)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
690
Holders Change
+22
Holders Change %
+3.29%
% of All Funds
14.99%
Holding in Top 10
12
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.69%
% of All Funds
0.26%
New
75
Increased
239
Reduced
248
Closed
46
Calls
$21.2M
Puts
$14.2M
Net Calls
+$6.96M
Net Calls Change
-$3.39M

XYL Hedge Fund Activity: Q2 2019 in Review

690 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q2 2019, worth a combined $13.4B — up 7.2% from $12.5B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new XYL positions and 46 closed out — a net gain of 29 holders — while 239 added to existing stakes and 248 trimmed.

The largest buyer was Nuveen, adding an estimated $44.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $91.7M.

  • 690 institutional investors held Xylem (XYL) as of Q2 2019, up from 668 in Q1 2019.
  • Funds reported $13.4B of Xylem stock for Q2 2019, up 7.2% quarter-over-quarter.
  • 75 funds opened new Xylem positions in Q2 2019 and 46 closed out, a net change of +29 holders.
  • The largest Xylem buyer in Q2 2019 was Nuveen, an estimated $44.4M added.
  • The largest Xylem seller in Q2 2019 was T. Rowe Price Associates, an estimated $91.7M sold.

Based on aggregated 13F filings for Q2 2019.